1.	Improve the Treatment of Thoracic Esophageal Cancer Phase: Phase III Type: Treatment Status: Active Age: 70 and other Sponsor: Other Protocol IDs: 2007044, NCT01137123
2.	A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: GuangxiMU, NCT01479504
3.	Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma Phase: Phase III Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: Sun Yat-sen University, NCT01540136
4.	Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 to 80 Sponsor: Other Protocol IDs: Daping H 001, NCT01265147
5.	Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: CH-GYN-001, 11-92/527, NCT01667211
6.	An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: TOP009-062, NCT01040312
7.	Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC) Phase: No phase specified Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: DO201001, DO210101, NCT01201044